fbpx

JÄÄB ÄRA: Kohtumine USA biotehnoloogia firma Miromatrixi juht Jeff Rossiga

  • 24.04.19
  • 15:30 - 17:00
  • Tehnopoli sündmus

Teaduspargi 6/1, Merkuur

Meil on hea meel kutsuda teid kohtumisele Jeff Rossiga, kes on USA biotehnoloogia MiroMatrixi juht. Hr Ross annab kohtumisel ülevaate  USA biotehnoloogia turu trendidest ja välisfirmade võimalustest ja barjääridest USA turule sisenemiseks ja arutame koostöövõimalusi Eesti ettevõtetega.

Kohtumine on ingliskeeles.

Üritusel osalemiseks palun regiustreeri hiljemalt 22.04 ennast siin.

JEFF ROSS, PH.D, CEO  

Dr. Ross brings more than 20 years of biomedical research, management and regulatory experience in regenerative medicine, biologics, and medical devices to Miromatrix including concept development, preclinical, clinical, manufacturing, and commercialization.  He has held various technical and management positions at Guidant, Athersys and SurModics.  Since coming to Miromatrix in 2010 he has been pivotal in the development, manufacturing and regulatory clearance of the innovative MIROMESH and MIRODERM product lines.  He has spearheaded development, global patent strategy, and fundraising for the revolutionary whole organ transplant program and its key decellularization technology.  Dr. Ross has over 30 patents along with scientific publications in Nature and other peer reviewed journals.  He holds a master’s degree in Biomedical Engineering and a Ph.D. in Molecular, Cellular and Developmental Biology from the University of Minnesota.

Ole kursis põnevate innovatsiooniuudistega

Meie partnerid